Ignite Creation Date:
2024-05-05 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 9:53 AM
Study NCT ID:
NCT00725738
Status:
UNKNOWN
Last Update Posted:
2008-07-30
First Post:
2008-07-28
Brief Title:
Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction TRACIA STUDY
Sponsor:
National Heart Institute Mexico
Organization:
National Heart Institute Mexico
Study Overview
Official Title:
Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction TRACIA Study
Status:
UNKNOWN
Status Verified Date:
2008-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRACIA
Brief Summary:
The purpose of this study is to evaluate the ejection fraction EF increase at 6 months follow up and major adverse cardiovascular events MACE after intracoronary autologous stem cell transplantation in ST elevation myocardial infarction patients versus a control group
Detailed Description:
Experimental trials with bone marrow cell have suggested that adult stem cell can contribute to regeneration of infarcted myocardial muscle and increase the neovascularization of the ischemic tissue
Post-myocardial infarction heart failure secondary to ventricular remodelation its an increasing problem A novel therapeutic approach for decrease this consequence is to induce the angiogeneses and regeneration of myocardial cells
Many trials have shown benefits through the intracoronary injection of stem cell however the clinical benefit is still controversial The present trial is a randomized single blinded controlled trial designed to evaluate the improvement on EF and survival in post ST elevation myocardial infarction patients undergoing to intracoronary autologous stem cell transplantation
Post-myocardial infarction heart failure secondary to ventricular remodelation its an increasing problem A novel therapeutic approach for decrease this consequence is to induce the angiogeneses and regeneration of myocardial cells
Many trials have shown benefits through the intracoronary injection of stem cell however the clinical benefit is still controversial The present trial is a randomized single blinded controlled trial designed to evaluate the improvement on EF and survival in post ST elevation myocardial infarction patients undergoing to intracoronary autologous stem cell transplantation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None